17β-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of a combination capsule and evidence review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

17β-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of a combination capsule and evidence review

Published:2015-05 Issue:1 Volume:81 Page:28-35
ISSN:0378-5122
Container-title:Maturitas
language:en
Short-container-title:Maturitas

Author:

Mirkin Sebastian,Amadio Julia M.,Bernick Brian A.,Pickar James H.,Archer David F.

Funder

TherapeuticsMD, Inc

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,General Biochemistry, Genetics and Molecular Biology

Reference59 articles.

1. The 2012 hormone therapy position statement of: the North American Menopause Society;North American Menopause Society;Menopause,2012

2. Management of the menopause-related symptoms;National Institute of Health State-of-the-Science Panel;Ann Intern Med,2005

3. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial;Rossouw;JAMA,2002

4. A decade of postmenopausal hormone therapy prescribing in the United States: long-term effects of the Women's Health Initiative;Steinkellner;Menopause,2012

5. A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999–2010;Sprague;Obstet Gynecol,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Selection of Impurities, Development, and Validation of Related Substance Methods for Estradiol and Progesterone in a Combination Drug Product;J AOAC INT;2023

2. Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial;The Lancet;2022-11

3. Bioidentical Oral 17β-Estradiol and Progesterone for the Treatment of Moderate to Severe Vasomotor Symptoms of Menopause;Annals of Pharmacotherapy;2020-12-21

4. Determinants of attained estradiol levels in response to oral estradiol plus progesterone therapy;Climacteric;2020-11-12

5. A current perspective into young female sex hormone replacement: a review;Expert Review of Endocrinology & Metabolism;2020-09-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3